NCT00466440 2020-11-06A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer PatientsEli Lilly and CompanyPhase 2 Completed108 enrolled 22 charts